首页> 外文期刊>International journal of infectious diseases: IJID : official publication of the International Society for Infectious Diseases >Mutation in pfmdr1 gene in chloroquine-resistant Plasmodium falciparum isolates, Southeast Iran.
【24h】

Mutation in pfmdr1 gene in chloroquine-resistant Plasmodium falciparum isolates, Southeast Iran.

机译:伊朗东南部抗氯喹恶性疟原虫分离株中pfmdr1基因的突变。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: The main objective of the present study was to detect point mutations at positions 86, 184, 1034, 1042, and 1246 of the Plasmodium falciparum multidrug resistance gene (pfmdr1) in blood samples collected from malaria patients in Chabahar, a harbor city located in Southeast Iran. METHODS: Twenty-six blood samples from patients infected with P. falciparum, who had a chloroquine (CQ) response failure, were collected pre-treatment. Following treatment with CQ, drug susceptibility was assessed using an in vivo test. Molecular detection of single nucleotide polymorphisms (SNPs) was carried out using the LightCycler hybridization probe assay. RESULTS: The pfmdr1 N86Y mutation was found in six isolates (23.1%). Mutations at the four other positions were not observed in any isolates. CONCLUSION: The present study showed no mutation at codon positions 184, 1034, 1042, and 1246 of pfmdr1 in any of the Iranian P. falciparum isolates; thus these alleles cannot serve as markers for CQ resistance in Iran.
机译:目的:本研究的主要目的是在从位于港口城市恰巴哈尔(Chabahar)的疟疾患者身上采集的血液样本中检测恶性疟原虫多药耐药基因(pfmdr1)86、184、1034、1042和1246位的点突变在伊朗东南部。方法:在治疗前收集了26例接受氯喹(CQ)反应失败的恶性疟原虫感染患者的血液样本。用CQ治疗后,使用体内试验评估药物敏感性。使用LightCycler杂交探针测定法对单核苷酸多态性(SNP)进行分子检测。结果:在6个分离株中发现了pfmdr1 N86Y突变(23.1%)。在任何分离物中均未观察到其他四个位置的突变。结论:本研究显示在伊朗恶性疟原虫中,pfmdr1的密码子位置184、1034、1042和1246没有突变。因此,这些等位基因不能作为伊朗抗CQ的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号